To target the untargetable: elucidation of synergy of APR-246 and azacitidine in TP53 mutant myelodysplastic syndromes and acute myeloid leukemia
oleh: David A. Sallman
| Format: | Article |
|---|---|
| Diterbitkan: | Ferrata Storti Foundation 2020-06-01 |
Deskripsi
No description available for this item.